Key result
Apigenin-7-O-β-d-(6″-p-coumaroyl)-glucopyranoside (APG) significantly reduced infarct size (16.2%) and inflammatory markers in a rat model of myocardial ischaemia/reperfusion injury (p < 0.05).
Why the study?
To investigate the cardioprotective effects of apigenin-7-O-β-d-(6″-p-coumaroyl)-glucopyranoside (APG) against myocardial ischaemia/reperfusion injury and elucidate the possible mechanism.
p-value: p=< 0.05
APG demonstrates cardioprotective effects against myocardial ischemia/reperfusion injury in experimental models by reducing the inflammatory response via NF-κB suppression.
APG may attenuate MI/RI in animal models; leaves open any clinical role or mechanism in humans.
Context Traditionally, Clematis tangutica Korsh. (Ranunculaceae) is used as a Tibetan herb for treating indigestion and blood stasis in China. Recently, a flavonoid glycoside, apigenin-7-O-β-d-(6″-p-coumaroyl)-glucopyranoside (APG), was isolated from the whole plant of C. tangutica.Objective To investigate the cardioprotective effects of APG against myocardial ischaemia/reperfusion injury (MI/RI) and the possible mechanism.Materials and methods Animals were subjected to 30 min/3 h MI/RI model. At the end of reperfusion, infarct size (IS), histopathology, serum levels CK-MB, LDH, TNF-α, IL-6 and MPO activities were detected. Phospho-IκB-α, ICAM-1 and NF-κB were assessed in vivo. Neonatal rat cardiomyocytes were pre-treated with or without APG, followed by stimulation with 8 h/2 h oxygen and glucose deprived/reoxygenation (OGD/R) model. Cell viability, LDH and cardiomyocyte apoptosis were assessed. The expression levels of phospho-IκB-α and NF-κB were measured in vitro.Results Treatment with APG significantly reduced the following indicators in vivo (p < 0.05): (1) the IS (16.2%); (2) morphology score (1.67); (3) myocardial injury enzymes: CK-MB (26.2 ng/mL) and LDH (688 U/L); (4) pro-inflammatory cytokines: TNF-α (31.5 pg/mL) and IL-6 (163.8 pg/mL); (5) MPO activity (2.75 U/mg); (6) expression levels of phospho-IκB-α (0.47), NF-κB (2.87) and ICAM-1 (10.2). Moreover, treatment with APG also remarkably (p < 0.05) attenuated the following indicators in vitro: (1) LDH level (206 U/L); (2) cardiomyocyte apoptosis; (3) phospho-IκB-α (1.37) and NF-κB (2.50).Conclusions APG possesses protective effects against MI/RI injury in rats and OGD/R-induced injury in cardiomyocytes by suppressing translocation of NF-κB and reducing inflammatory response; consequently, APG is helpful for treatment of ischaemic heart disease.
No takes yet. Share an insight, caveat, or question.
Quan et al. (2019) studied Myocardial ischaemia/reperfusion injury. Apigenin-7-O-β-d-(6″-p-coumaroyl)-glucopyranoside (APG) vs. Control (without APG) was evaluated on Infarct size (p=< 0.05). Apigenin-7-O-β-d-(6″-p-coumaroyl)-glucopyranoside (APG) significantly reduced infarct size (16.2%) and inflammatory markers in a rat model of myocardial ischaemia/reperfusion injury (p < 0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: